The results of a new study show that the incidence of Parkinson’s disease (PD), or the number of new...see more cases diagnosed per year, is 50% higher than previously estimated. Instead of past estimates of 60,000 new cases of PD diagnosed per year, the new study determined that there are approximately 90,000 new cases of PD […]

Read More

You may have seen a recent episode of the TODAY show which highlighted a fascinating device developed at Stanford...see more University – a glove that imparts vibration to the fingertips in order to relieve Parkinson’s disease (PD) symptoms. In a small trial, participants wore the glove on each hand for several hours a day. The results […]

Read More

In an exciting new study, researchers at Brigham and Women’s Hospital in Boston, MA, led by APDA Cotzias Fellowship*...see more awardee Dr. Vikram Khurana, demonstrated a new role for the protein involved in Parkinson’s disease (PD) pathology, alpha-synuclein. In addition to alpha-synuclein interacting with vesicles, or small transport structures within the cell, this new study shows […]

Read More

May 6, 2021 In an exciting new study, researchers at the APDA Center for Advanced Research at Brigham and...see more Women’s Hospital studied the genetic changes that increase the rate of progression of Parkinson’s disease (PD). Currently, there are many genes that are associated with an increased risk of developing PD. But once a person has […]

Read More

Adamas announced that the Food and Drug Administration (FDA) approved Gocovri for a second indication – as an add-on...see more treatment to carbidopa/levodopa in Parkinson’s disease (PD) patients who are experiencing OFF episodes. Previously, Gocovri was only approved for treatment of Levodopa-induced dyskinesias. You can learn more about managing dyskinesias and OFF episodes in this webinar. […]

Read More

Abbott, one of the manufacturers of deep brain stimulation (DBS) devices for Parkinson’s disease (PD) recently released NeuroSphereTM Virtual...see more Clinic, a technology that allows for virtual visits between patients and their DBS neurologist and is the first system to allow for remote programming of the DBS device. Currently, a device can be programmed so that […]

Read More

In an exciting new study, researchers at the APDA-funded Center studied the relationship between the activity of the glucocerebrosidase...see more (GBA) enzyme and the risk of Parkinson’s disease (PD). This insight may help shed light on possible future treatments. The glucocerebrosidase (GBA) enzyme, encoded by the GBA gene, is a protein used by the body to […]

Read More

Medtronic announces introduction of Percept PC Neurostimulator with Brainsense Technology On June 26, 2020 Medtronic announced the introduction of...see more an upgraded deep brain stimulation (DBS) system known as PerceptTM PC Neurostimulator with BrainsenseTM Technology. The technology in the new system is the first to not only deliver electrical stimulation to the brain, with the goal […]

Read More

All of us at the American Parkinson Disease Association (APDA) support equality for all and reject racism.  Our programs...see more are open to everyone and we foster a safe and welcoming place for all to join us, whether virtually or in person.  Disparities and injustice exist on many levels, including within the healthcare system. At APDA, […]

Read More